Interrelated factors in hypertensive patients

Por Fuller, John H, Shipley, M J, Rose, Geoffrey
Publicado em 1978

Cross sectional study of differences in coronary artery calcification by socioeconomic status

Por Colhoun, Helen M, Rubens, Michael B, Underwood, S Richard, Fuller, John H
Publicado em 2000

Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)

Por Soedamah-Muthu, Sabita S., Chaturvedi, Nish, Witte, Daniel R., Stevens, Lynda K., Porta, Massimo, Fuller, John H.
Publicado em 2008

Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors

Por Elliott, Jackie, Tesfaye, Solomon, Chaturvedi, Nish, Gandhi, Rajiv A., Stevens, Lynda K., Emery, Celia, Fuller, John H.
Publicado em 2009

Low Peripheral Nerve Conduction Velocities and Amplitudes Are Strongly Related to Diabetic Microvascular Complications in Type 1 Diabetes: The EURODIAB Prospective Complications St...

Por Charles, Morten, Soedamah-Muthu, Sabita S., Tesfaye, Solomon, Fuller, John H., Arezzo, Joseph C., Chaturvedi, Nishi, Witte, Daniel R.
Publicado em 2010

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the E...

Por Peeters, Stijn A, Engelen, Lian, Buijs, Jacqueline, Chaturvedi, Nish, Fuller, John H, Schalkwijk, Casper G, Stehouwer, Coen D
Publicado no Cardiovasc Diabetol (2015)

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 dia...

Por Peeters, Stijn A, Engelen, Lian, Buijs, Jacqueline, Chaturvedi, Nish, Fuller, John H, Schalkwijk, Casper G, Stehouwer, Coen D
Publicado no Cardiovasc Diabetol (2015)

QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study

Por Gruden, Gabriella, Giunti, Sara, Barutta, Federica, Chaturvedi, Nish, Witte, Daniel R., Tricarico, Marinella, Fuller, John H., Cavallo Perin, Paolo, Bruno, Graziella
Publicado em 2012

Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study

Por Gruden, Gabriella, Barutta, Federica, Chaturvedi, Nish, Schalkwijk, Casper, Stehouwer, Coen D., Witte, Daniel R., Fuller, John H., Cavallo Perin, Paolo, Bruno, Graziella
Publicado em 2012

Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study

Por Engelen, Lian, Soedamah-Muthu, Sabita S., Geleijnse, Johanna M., Toeller, Monika, Chaturvedi, Nish, Fuller, John H., Schalkwijk, Casper G., Stehouwer, Coen D. A.
Publicado em 2014

Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study : A Novel Circulating Marker for Diabetic Neuropathy

Por Gruden, Gabriella, Bruno, Graziella, Chaturvedi, Nish, Burt, Davina, Schalkwijk, Casper, Pinach, Silvia, Stehouwer, Coen D., Witte, Daniel R., Fuller, John H., Perin, Paolo Cavallo
Publicado em 2008

Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study

Por Burt, Davina, Bruno, Graziella, Chaturvedi, Nish, Schalkwijk, Casper, Stehouwer, Coen D., Witte, Daniel R., Fuller, John H., Pinach, Silvia, Cavallo Perin, Paolo, Gruden, Gabriella
Publicado em 2009

Low 25-hydroxyvitamin D(2) and 25-hydroxyvitamin D(3) levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabet...

Por Engelen, Lian, Schalkwijk, Casper G., Eussen, Simone J. P. M., Scheijen, Jean L. J. M., Soedamah-Muthu, Sabita S., Chaturvedi, Nish, Fuller, John H., Stehouwer, Coen D. A.
Publicado no Cardiovasc Diabetol (2015)

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)

Por Livingstone, Shona J., Looker, Helen C., Akbar, Tahira, Betteridge, D. John, Durrington, Paul N., Hitman, Graham A., Neil, H. Andrew W., Fuller, John H., Colhoun, Helen M.
Publicado no Diabetologia (2015)

NH(2)-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α

Por Gruden, Gabriella, Barutta, Federica, Chaturvedi, Nish, Schalkwijk, Casper, Stehouwer, Coen D., Pinach, Silvia, Manzo, Maria, Loiacono, Maria, Tricarico, Marinella, Mengozzi, Giulio, Witte, Daniel R., Fuller, John H., Perin, Paolo Cavallo, Bruno, Graziella
Publicado em 2012

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Ana...

Por Colhoun, Helen M., Betteridge, D. John, Durrington, Paul, Hitman, Graham, Neil, Andrew, Livingstone, Shona, Charlton-Menys, Valentine, Bao, Weihang, DeMicco, David A., Preston, Gregory M., Deshmukh, Harshal, Tan, Kathryn, Fuller, John H.
Publicado em 2011

Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors

Por Yan, Dong, Wiesmann, Marion, Rohan, Michael, Chan, Vivien, Jefferson, Ann B., Guo, Lida, Sakamoto, Doreen, Caothien, Roger H., Fuller, John H., Reinhard, Christoph, Garcia, Pablo D., Randazzo, Filippo M., Escobedo, Jaime, Fantl, Wendy J., Williams, Lewis T.
Publicado em 2001

Predicting major outcomes in type 1 diabetes: a model development and validation study

Por Soedamah-Muthu, Sabita S., Vergouwe, Yvonne, Costacou, Tina, Miller, Rachel G., Zgibor, Janice, Chaturvedi, Nish, Snell-Bergeon, Janet K., Maahs, David M., Rewers, Marian, Forsblom, Carol, Harjutsalo, Valma, Groop, Per-Henrik, Fuller, John H., Moons, Karel G.M., Orchard, Trevor J.
Publicado no Diabetologia (2014)

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

Por Soedamah-Muthu, Sabita S., Livingstone, Shona J., Charlton-Menys, Valentine, Betteridge, D. John, Hitman, Graham A., Neil, H. Andrew W., Bao, Weihang, DeMicco, David A., Preston, Gregory M., Fuller, John H., Stehouwer, Coen D. A., Schalkwijk, Casper G., Durrington, Paul N., Colhoun, Helen M.
Publicado no Diabetologia (2015)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)

Por Deshmukh, Harshal A., Colhoun, Helen M., Johnson, Toby, McKeigue, Paul M., Betteridge, D. John, Durrington, Paul N., Fuller, John H., Livingstone, Shona, Charlton-Menys, Valentine, Neil, Andrew, Poulter, Neil, Sever, Peter, Shields, Denis C., Stanton, Alice V., Chatterjee, Aurobindo, Hyde, Craig, Calle, Roberto A., DeMicco, David A., Trompet, Stella, Postmus, Iris, Ford, Ian, Jukema, J. Wouter, Caulfield, Mark, Hitman, Graham A.
Publicado em 2012